Stavudine (RMML-00120502)
Cat. No.: RMML-00120502
Category: Inhibitors & Activators
INQUIRY
1 mg
5 mg
Inhibit HIV replication and cancer cell growth with stavudine, a nucleoside analog of thymidine and HIV reverse transcriptase inhibitor. After phosphorylation by kinases, stavudine turns into stavudine triphosphate, a compound that competes with the natural substrate thymidine triphosphate for incorporation into viral DNA by HIV reverse transcriptase . When stavudine triphosphate is incorporated into the viral DNA chain, it terminates DNA replication prematurely and inhibits HIV replication. Reported to induce cellular senescence in human fibroblasts. Fibroblasts treated with stavudine exhibited mitochondrial dysfunction, slowed division rates, and increased ROS levels in early culture passages. In later passages, fibroblasts became senescent on the basis of p16 and p21 protein expression and senescence-associated-beta-galactosidase activity. Reduces NLRP3 inflammasome-associated inflammation and stimulates Aβ autophagy by THP-1-derived macrophages in an in vitro model of Alzheimer's disease.
Product Features
Purity | ≥ 98% |
---|
Compound Information
Alternative Names | BMY 27857, d4T, Zerit |
---|---|
CAS Number | 3056-17-5 |
Molecular Formula | C10H12N2O4 |
Molecular Weight | 224.2 Da |
Storage & Shipping
Handling | Refer to SDS for further information. |
---|
For research use only. Not for clinical use.